MMP-13 inhibitors (Pfizer)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameMMP-13 inhibitors (Pfizer)

Drug Alias NamePD-156PF-152PD-503PF-212PF-80

ClassificationSmall molecules

Mechanisms of ActionMatrix metalloproteinase 13 inhibitors

TargetsMatrix metalloproteinase 13

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsInflammation

ATC CodeN/A